Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex

FEMS Yeast Research

Volumn 13, Issue 8, 2013, Pages 831-848

  Abi chacra, Érika A ^a   Souza, Lucieri O P ^a   Cruz, Lucas P ^a   Braga Silva, Lys A ^a   Gonçalves, Diego S ^a   Sodré, Cátia L ^a,b   Ribeiro, Marcos D ^a   Seabra, Sergio H ^c   Figueiredo Carvalho, Maria H G ^d   Barbedo, Leonardo S ^d   Zancopé Oliveira, Rosely M ^d   Ziccardi, Mariangela ^a,e   Santos, André L S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Centro Universitário Estadual da Zona Oeste UEZO   (Brazil)

^d Funda??o Oswaldo Cruz   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Candida parapsilosis complex; Hydrolytic enzymes; Interaction process; Morphogenesis; Surface glycoconjugates; Surface hydrophobicity

Indexed keywords

CATALASE; ESTERASE; HEMOLYSIN; PHYTASE; PROTEINASE; SIALIC ACID;

ARTICLE; BIOFILM; CANDIDA PARAPSILOSIS; CELL ADHESION; CONTROLLED STUDY; FIBROBLAST; FUNGAL CELL; FUNGAL VIRULENCE; HYDROPHOBICITY; MAMMAL CELL; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION;

CANDIDA PARAPSILOSIS; MAMMALIA;

CANDIDA PARAPSILOSIS COMPLEX; HYDROLYTIC ENZYMES; INTERACTION PROCESS; MORPHOGENESIS; SURFACE GLYCOCONJUGATES; SURFACE HYDROPHOBICITY;

BIOFILMS; CANDIDA; CELL MEMBRANE; GLYCOSYLATION; HUMANS; HYDROLYSIS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR TYPING; PHENOTYPE; PHYLOGENY; RNA, FUNGAL; RNA, RIBOSOMAL, 28S; VIRULENCE;

EID: 84887613460     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/1567-1364.12092     Document Type: Article

References (69)

1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
2. Aktas E, Yigit N & Ayyildiz A (2002) Esterase activity in various Candida species. J Int Med Res 30: 322-324.
3. Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, Alonso-Tarres C, Rodriguez-Tudela JL & Pahissa A (2006) Epidemiology, risk factors and prognosis of Candida parapsilosis bloodstream infection: case-control population-based surveillance study of patients in Barcelona from 2002 to 2003. J Clin Microbiol 44: 1681-1685.
4. Alviano CS, Travassos LR & Schauer R (1999) Sialic acids in fungi: a minireview. Glycoconj J 9: 545-554.
5. Asadzadeh M, Ahmad S, Al-Sweih N & Khan ZU (2009) Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol 58: 745-752.
6. Bertini A, De Bernardis F, Hensgens LA, Sandini S, Senesi S & Tavanti A (2013) Comparison of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis adhesive properties and pathogenicity. Int J Med Microbiol 2: 98-103.
7. Braga-Silva LA & Santos ALS (2011) Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis. Curr Med Chem 18: 2401-2419.
8. Braga-Silva LA, Mogami SS, Valle RS, Silva-Neto ID & Santos ALS (2010) Multiple effects of amprenavir against Candida albicans. FEMS Yeast Res 10: 221-224.
9. Cantón E, Pemán J, Quindós G et al. (2011) Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother 55: 5590-5596.
10. Chaka W, Scharringa J, Verheul AF, Verhoef J, Van Strijp AG & Hoepelman IM (1995) Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry. Clin Diagn Lab Immunol 2: 753-759.
11. Das I, Nightingale P, Patel M & Jumaa P (2011) Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 15: e759-e763.
12. De Bernardis F, Mondello F, San Millan R, Ponton J & Cassone A (1999) Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol 37: 3481-3486.
13. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36.
14. França EJ, Furlaneto-Maia L, Quesada RM, Favero D, Oliveira MT & Furlaneto MC (2011) Haemolytic and proteinase activities in clinical isolates of Candida parapsilosis and Candida tropicalis with reference to the isolation anatomic site. Mycoses 54: e44-e51.
15. Free SJ (2013) Fungal cell wall organization and biosynthesis. Adv Genet 81: 33-82.
16. Gacser A, Schafer W, Nosanchuk JS, Salomon S & Nosanchuk JD (2007) Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol 44: 1336-1341.
17. Garcia-Effron G, Canton E, Pemán J, Dilger A, Romá E & Perlin DS (2011) Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species. J Clin Microbiol 49: 3257-3261.
18. Ge YP, Lu GX, Shen YN & Liu WD (2012) In vitro evaluation of phospholipase, proteinase, and esterase activities of Candida parapsilosis and Candida metapsilosis. Mycopathologia 172: 429-438.
19. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol 13: 122-143.
20. Gomez-Lopez A, Alastruey-Izquierdo A, Rodrigues D, Almirante B, Pahissa A, Rodriguez-Tudela JL & Cuenca-Estrella M (2008) Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother 52: 1506-1509.
21. González-Párraga P, Sánchez-Fresneda R, Martínez-Esparza M & Argüelles JC (2008) Stress responses in yeasts: what rules apply? Arch Microbiol 189: 293-296.
22. Haynes K (2001) Virulence in Candida species. Trends Microbiol 9: 591-596.
23. Hays C, Duhamel C, Cattoir V & Bonhomme J (2011) Rapid and accurate identification of species belonging to the Candida parapsilosis complex by real-time PCR and melting curve analysis. J Med Microbiol 60: 477-480.
24. Hazen KC, Plotkin BJ & Klimas DM (1986) Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata. Infect Immun 54: 269-271.
25. Horváth P, Nosanchuk JD, Hamari Z, Vágvölgyi C & Gácser A (2012) The identification of gene duplication and the role of secreted aspartyl proteinase 1 in Candida parapsilosis virulence. J Infect Dis 205: 923-933.
26. Hrusková-Heidingsfeldová O, Dostál J, Majer F, Havlíkova J, Hradilek M & Pichová I (2009) Two aspartic proteinases secreted by the pathogenic yeast Candida parapsilosis differ in expression pattern and catalytic properties. Biol Chem 390: 259-268.
27. Hube B & Naglik J (2001) Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147: 1997-2005.
28. Kantarcioglu AS & Yucel A (2002) Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 45: 160-165.
29. Klotz SA, Drutz DJ & Zajic JE (1985) Factors governing adherence of Candida species to plastic surfaces. Infect Immun 50: 97-101.
30. Konopka JB (2012) N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica (Cairo) 1: 489208.
31. Kuhn DM, Chandra J, Mukherjee PK & Ghannoum MA (2002) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70: 878-888.
32. Laffey SF & Butler G (2005) Phenotype switching affects biofilm formation by C. parapsilosis. Microbiology 151: 1073-1081.
33. Lattif AA, Mukherjee PK, Chandra J, Swindell K, Lockhart SR, Diekema DJ, Pfaller MA & Ghannoum MA (2010) Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis and C. orthopsilosis. Int J Med Microbiol 300: 265-270.
34. Lefkowitz SS, Gelderman MP, Lefkowitz DL, Moguilevsky N & Bollen A (1996) Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J Infect Dis 173: 1202-1207.
35. Lei XG & Porres JM (2003) Phytase enzymology, applications, and biotechnology. Biotechnol Lett 25: 1787-1794.
36. Lima-Neto RG, Beltrão EIC, Oliveira PC & Neves RP (2011) Adherence of Candida albicans and Candida parapsilosis to epithelial cells correlates with fungal cell surface carbohydrates. Mycoses 54: 23-29.
37. Lockhart SR, Messer SA, Pfaller MA & Diekema DJ (2008) Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol 46: 2659-2664.
38. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
39. Luo G, Samaranayake LP & Yau JY (2001) Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 39: 2971-2974.
40. Nayak AP, Green BJ & Beezhold DH (2013) Fungal hemolysins. Med Mycol 51: 1-16.
41. Nosek J, Holesova Z, Kosa P, Gacser A & Tomaska L (2009) Biology and genetics of the pathogenic yeast Candida parapsilosis. Curr Genet 55: 497-509.
42. Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A & Colombo AL (2010) Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 51: 561-570.
43. Oliveira MT, Specian AF, Andrade CG, França EJ, Furlaneto-Maia L & Furlaneto MC (2010) Interaction of Candida parapsilosis isolates with human hair and nail surfaces revealed by scanning electron microscopy analysis. Micron 41: 604-608.
44. Olstorpe M, Schnürer J & Passoth V (2009) Screening of yeast strains for phytase activity. FEMS Yeast Res 9: 478-488.
45. Orsi CF, Colombari B & Blasi E (2010) Candida metapsilosis as the least virulent member of the 'C. parapsilosis' complex. Med Mycol 48: 1024-1033.
46. Panagoda GJ & Samaranayake LP (1998) The relationship between the cell length, adhesion to acrylic and relative cell surface hydrophobicity of Candida parapsilosis. Med Mycol 36: 373-378.
47. Panagoda GJ, Ellepola AN & Samaranayake LP (2011) Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity. Mycoses 44: 29-35.
48. Paraje MG, Correa SG, Renna MS, Theumer M & Sotomayor CE (2008) Candida albicans-secreted lipase induces injury and steatosis in immune and parenchymal cells. Can J Microbiol 54: 647-659.
49. Peeters E, Nelis HJ & Coenye T (2008) Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 72: 157-165.
50. Pfaller MA & Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
51. Price MF, Wilkinson ID & Gentry LO (1982) Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20: 7-14.
52. Reinhart H, Muller G & Sobel JD (1985) Specificity and mechanism of in vitro adherence of Candida albicans. Ann Clin Lab Sci 15: 406-413.
53. Romeo O, Delfino D, Costanzo B, Cascio A & Criseo G (2012) Molecular characterization of Italian Candida parapsilosis isolates reveals the cryptic presence of the newly described species Candida orthopsilosis in blood cultures from newborns. Diagn Microbiol Infect Dis 72: 234-238.
54. Rüchel J, Tegeler R & Trost MA (1982) Comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia 20: 233-244.
55. Sangetha S, Zuraini Z, Suryani S & Sasidharan S (2009) In situ TEM and SEM studies on the antimicrobial activity and prevention of Candida albicans biofilm by Cassia spectabilis extract. Micron 40: 439-443.
56. Shibata N, Kobayashi H & Suzuki S (2012) Immunochemistry of pathogenic yeast, Candida species, focusing on mannan. Proc Jpn Acad Ser B Phys Biol Sci 88: 250-265.
57. Shimizu MT, Almeida NQ, Fantinato V & Unterkircher CS (1996) Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses 39: 161-167.
58. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C & Rodrigues AG (2009) Prevalence, distribution and antifungal susceptibility profile of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in a tertiary care hospital. J Clin Microbiol 47: 2392-2397.
59. Silva S, Negri M, Henriques M, Oliveira R, Williams DW & Azeredo J (2012) Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 36: 288-305.
60. Singh AK & Mukhopadhyay M (2012) Overview of fungal lipase: a review. Appl Biochem Biotechnol 166: 486-520.
61. Sundstrom P (2002) Adherence in Candida spp. Cell Microbiol 4: 461-469.
62. Tavanti A, Davidson AD, Gow NA, Maiden MC & Odds FC (2005) Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 43: 284-292.
63. Tavanti A, Hensgens LAM, Ghelardi E, Campo M & Senesi S (2007) Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbiol 45: 1455-1462.
64. Tavanti A, Hensgens LA, Mogavero S, Majoros L, Senesi S & Campa M (2010) Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites. BMC Microbiol 10: 203-213.
65. Trofa D, Gácser A & Nosanchuk JD (2008) Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 21: 606-625.
66. Tsang PW (2011) Differential phytate utilization in Candida species. Mycopathologia 172: 473-479.
67. Tumbarello M, Posteraro B, Trecarichi EM et al. (2007) Biofilm production by Candida species and inadequate antifungal therapy as predictor of mortality for patients with candidemia. J Clin Microbiol 45: 1843-1850.
68. van Asbeck EC, Clemons KV & Stevens DA (2009) Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Crit Rev Microbiol 35: 283-309.
69. Wysong DR, Christin L, Sugar AM, Robbins PW & Diamond RD (1998) Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infect Immun 66: 1953-1961.